Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and tolerability of saxagliptin compared to glimepiride
in elderly patients with type 2 diabetes mellitus who have inadequate glycaemic control on
metformin monotherapy.